Amicus Therapeutics, Inc. (NASDAQ:FOLD) currently has a Zacks Rank #2 (Buy). Amicus Therapeutics, Inc. (NASDAQ:FOLD) belongs to Healthcare sector. Its weekly performance is 34.38%. On last trading day company shares ended up $7.27. Amicus Therapeutics, Inc. (NASDAQ:FOLD) distance from 50-day simple moving average (SMA50) is 76.12%. EMC (NYSE:EMC) declared a quarterly dividend on Friday, August 1st. Investors of record on Wednesday, October 1st will be given … Continue reading Morning Alert: Amicus Therapeutics (NASDAQ:FOLD), EMC (NYSE:EMC), Rubicon Technology (NASDAQ:RBCN), Quest Rare Minerals Ltd. (NYSEMKT:QRM), Vera Bradley, Inc. (NASDAQ:VRA)